Concepedia

Wojciech Danysz

WD

Statistics

Publications

169

Citations

10.4K

H-Index

56

Active since

1983

Affiliations

MerLion Pharma (Germany)(Current)

Institute of Psychiatry and Neurology

First Pavlov State Medical University of St. Petersburg

Maj Institute of Pharmacology

Wojciech Danysz is an author at MerLion Pharma (Germany) specializing in neuropharmacology, neuroscience, and pharmacology.

Publications per year

1983–2021

169

Publications

169

Glutamate in CNS disorders as a target for drug development: an update

Chris G. Parsons, Wojciech Danysz, G. Quack · Drug News & Perspectives · 1998 · 447 citations

Life Sciences, Neuroscience, Pharmacology +17

Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo

Chris G. Parsons, G. Quack, I. Bresink et al. · Neuropharmacology · 1995 · 312 citations

Life Sciences, Neuroscience, Pharmacology +10

Glycine and D-serine increase the affinity of N-methyl-D-aspartate sensitive glutamate binding sites in rat brain synaptic membranes

Emanuela Fadda, Wojciech Danysz, Jarda T. Wroblewski et al. · Neuropharmacology · 1988 · 259 citations

Life Sciences, Neurobiology, Neuroscience +14

Learning impairment in rats by N-methyl-D-aspartate receptor antagonists

Wojciech Danysz · Neuropharmacology · 1988 · 223 citations

Medicine, Neuroscience, Pharmacology +12

Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model

Andrzej Dekundy, Martin Lundblad, Wojciech Danysz et al. · Behavioural Brain Research · 2007 · 217 citations

Medicine, Neuroscience, Pharmacology +16

1–5 of 169